0001193125-22-089748.txt : 20220330 0001193125-22-089748.hdr.sgml : 20220330 20220330160200 ACCESSION NUMBER: 0001193125-22-089748 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220324 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KEWAUNEE SCIENTIFIC CORP /DE/ CENTRAL INDEX KEY: 0000055529 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] IRS NUMBER: 380715562 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-05286 FILM NUMBER: 22786362 BUSINESS ADDRESS: STREET 1: 2700 W FRONT ST CITY: STATESVILLE STATE: NC ZIP: 28677 BUSINESS PHONE: 7048737202 MAIL ADDRESS: STREET 1: P O BOX 1842 CITY: STATESVILLE STATE: NC ZIP: 28687-1842 FORMER COMPANY: FORMER CONFORMED NAME: KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/ DATE OF NAME CHANGE: 19861216 FORMER COMPANY: FORMER CONFORMED NAME: KEWAUNEE MANUFACTURING CO DATE OF NAME CHANGE: 19680108 8-K 1 d340464d8k.htm 8-K 8-K
KEWAUNEE SCIENTIFIC CORP /DE/ false 0000055529 0000055529 2022-03-24 2022-03-24

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 24, 2022

 

 

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-5286   38-0715562
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

2700 West Front Street

Statesville, North Carolina

  28677
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 704-873-7202

 

 

N/A

(Former name or former address, if changed since last report.)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $2.50 par value   KEQU   NASDAQ Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 1.01

Entry into a Material Definitive Agreement.

On March 11, 2022, Kewaunee Scientific Corporation (the “Company”) entered into a Thirteenth Amendment to Credit and Security Agreement (the “Amendment”) with Wells Fargo Bank, National Association (the “Bank”), the effectiveness of which was conditioned upon the consummation of the Sale-Leaseback Arrangement (as defined and further described below in Item 2.01), which occurred on March 24, 2022. The Amendment made certain changes to the Credit and Security Agreement, dated as of May 6, 2013, as amended (the “Credit Agreement”), between the Company and the Bank, and to the Revolving Line of Credit Note, dated May 6, 2013, made by the Company and payable to the order of the Bank, as amended (the “Revolving Note”). The changes included (i) amending and replacing the $15,000,000 line of credit with a $7,500,000 line of credit; (ii) providing for the removal of liens on property of the Company previously existing pursuant to the terms of the Credit Agreement; (iii) changing the interest rate under the Credit Agreement such that interest shall accrue at a rate equal to the greater of (a) the Prime Rate (as defined in the Revolving Note) plus 1.1% and (b) 4.75%, in each case plus any default interest which may become applicable pursuant to the terms of clause (d) of the “Interest” section of the Revolving Note; (iv) consenting to the consummation of the Sale-Leaseback Arrangement; and (v) restating the amended Credit Agreement to reflect all amendments to date.

On March 24, 2022, under the terms of the previously announced Sale-Leaseback Arrangement (as defined and further described below in Item 2.01), the Company entered into a 20-year lease with CAI Investments Medical Products I Master Lessee, LLC, a Delaware limited liability company and affiliate of the buyer under the Sale-Leaseback Arrangement, CAI Investments Sub Series 100, LLC, a Nevada limited liability company (the “Lease Agreement”). In addition to the initial term of 20 years, the Company has a right to renew the Lease Agreement thereafter for four renewal terms of five years each. The Company’s initial basic rent under the Lease Agreement is approximately $158,000 per month, which rent will increase by approximately 2% each year of the initial term.

The foregoing descriptions are not intended to be complete descriptions of the Amendment and the Lease Agreement and are qualified in their entirety by reference to the full texts of the Amendment and the Lease Agreement, as applicable, copies of which will be filed as exhibits to the Company’s Annual Report on Form 10-K for the year ending April 30, 2022.

 

Item 2.01

Completion of Acquisition or Disposition of Assets.

On March 24, 2022, the Company completed the transactions contemplated by its previously announced sale-leaseback arrangement for the Company’s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina (the “Sale-Leaseback Arrangement”).

The Company sold the property for $30,275,000 and simultaneously entered into the Lease Agreement (as defined and further described above in Item 1.01).

After payment of fees and withholding of a repair fund of $161,012.50 and a capital expenditure account of $1,000,000, the Company’s net cash proceeds received upon closing equaled $13,643,472.80 (the “Net Cash Proceeds”). Additionally, the Company acquired $14,864,377.20 of preferred equity in CAI Investments Medical Products I Parent, LLC, a Delaware limited liability company (the “Preferred Equity”). The Preferred Equity will be purchased from the Company over a 30-day period, subject to a cure period of equal duration and backed by a guaranty from certain affiliates of the buyer (the “Preferred Equity Proceeds” and, together with the Net Cash Proceeds, the “Proceeds”). A portion of the Net Cash Proceeds was used to repay amounts outstanding under the Credit Agreement, and the remainder of the Proceeds is expected to be used for general corporate purposes.


In connection with the consummation of the Sale-Leaseback Arrangement, the Company also entered into a fourth amendment to the Agreement for Purchase and Sale of Real Property with the buyer, CAI Investments Sub Series 100, LLC, a Nevada limited liability company (the “Fourth Amendment”). The Fourth Amendment made certain changes to the terms and structure of the Sale-Leaseback Arrangement, resulting in the principal final terms described above.

The foregoing description of the Sale-Leaseback Arrangement is not intended to be a complete description of the Sale-Leaseback Arrangement or the documents governing the Sale-Leaseback Arrangement and is qualified in its entirety by reference to the full text of the Agreement for Purchase and Sale of Real Property, including all amendments to date, copies of which are incorporated by reference as Exhibits 10.1, 10.2, 10.3 and 10.4, and included as Exhibit 10.5, to this Current Report on Form 8-K.

 

Item 9.01

Financial Statements and Exhibits.

(d)    Exhibits

 

Exhibit
Number

  

Description

10.1    Agreement for Purchase and Sale of Real Property, dated as of December 22, 2021 between CAI Investments Sub Series 100, LLC and Kewaunee Scientific Corporation (incorporated herein by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on March 11, 2022).
10.2    Amendment 1 to the Agreement for Purchase and Sale of Real Property, dated January 21, 2022 (incorporated herein by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on March 11, 2022).
10.3    Amendment 2 to the Agreement for Purchase and Sale of Real Property, dated January 24, 2022 (incorporated herein by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q filed on March 11, 2022).
10.4    Amendment 3 to the Agreement for Purchase and Sale of Real Property, dated January 26, 2022 (incorporated herein by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q filed on March 11, 2022).
10.5    Amendment 4 to the Agreement for Purchase and Sale of Real Property, dated March 23, 2022.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

                  (Registrant)  
    Kewaunee Scientific Corporation  
Date: March 30, 2022    

/s/ Donald T. Gardner III

 
   

Donald T. Gardner III

Vice President, Finance

 
    Chief Financial Officer  
EX-10.5 2 d340464dex105.htm EX-10.5 EX-10.5

Exhibit 10.5

FOURTH AMENDMENT TO PURCHASE AGREEMENT

This Fourth Amendment to Purchase Agreement (this “Amendment”) is dated March 23, 2022 (the “Effective Date”), by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (“Seller”) and CAI INVESTMENTS SUB SERIES 100, LLC, a Nevada limited liability company, and/or its permitted assignee (“Buyer”).

RECITALS

WHEREAS, Buyer and Seller entered into that certain Agreement for Purchase and Sale of Real Property dated as of December 22, 2022 (as amended by that First Amendment to Purchase Agreement dated January 21, 2021, that Second Amendment to Purchase Agreement dated January 24, 2022, and that Third Amendment to Purchase Agreement dated January 26, 2022 (the “Third Amendment”; collectively, the “Agreement”), for that certain property located at 2700 West Front Street, Statesville, North Carolina as further described in the Agreement; and

WHEREAS, Buyer and Seller desire to amend the Agreement as set forth below.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein, Buyer and Seller hereby agree to amend the Agreement as follows:

1. Recitals. The recitals set forth above are true and correct and are hereby incorporated in their entirety. Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Agreement.

2. Lease.

(a) Exhibit C to the Agreement (i.e., the form of Lease) is hereby deleted and replaced with Exhibit C attached hereto.

(b) At Closing, Seller and Buyer agree to cause the execution of (i) that Memorandum of Lease in the form of Exhibit C-1 attached hereto and (ii) Subordination, Non-Disturbance and Attornment Agreement in the form of Exhibit C-2 attached hereto.

3. Letter Agreement. At Closing, Seller and Buyer agree to execute that Letter Agreement in the form of Exhibit D attached hereto.

4. Preferred Equity Documents.

(a) At Closing, Seller and Buyer (or its assign) agree to execute and deliver the Limited Liability Company Agreement of CAI Investments Medical Products I Parent, LLC in the form of Exhibit E attached hereto.

(b) At Closing, Buyer shall cause the Guaranty to be executed and delivered in the form of Exhibit F attached hereto.

(c) At Closing, Buyer shall cause the Trust Agreement of CAI Investments Medical Products I, DST to be executed and delivered in the form of Exhibit G attached hereto.

 

1


(d) At Closing, Buyer shall cause the Loan Agreement with Bank of Montreal as “Lender” to be executed and delivered in the form of Exhibit H attached hereto.

5. Property.

(a) Section 1(e) of the Agreement is hereby deleted and replaced with the following: “Property” shall mean: (a) that certain property located at 2700 West Front Street in Statesville, North Carolina, being also known as Iredell County Tax Parcel 4724791244.000, together with all improvements therein (including, without limitation, that +/- 416,299 square foot building thereon); and (b) all right, title and interest of Seller in and to all easements, licenses, rights and appurtenances relating to any of the foregoing.”

(b) Exhibit A to the Agreement and Exhibit A to the Lease attached as Exhibit C of the Agreement are hereby deleted and shall be replaced with the legal description of the Property as described in the Deed being simultaneously delivered from Seller to Buyer in connection with Closing and included in Buyer’s approved title proforma.

(c) The second and third sentences of Section 10(a) of the Agreement are hereby deleted and replaced with the following: “The legal description to be used in the Deed shall be derived from the Survey. Buyer shall cause the Survey to be certified to Buyer, Seller and such other parties as Buyer may request.”

6. Ratifications. Except as specifically modified and amended herein, all terms, provisions, conditions, and exhibits contained in the Agreement are hereby reinstated, confirmed, ratified, and shall remain unmodified and in full force and effect. In the event that any provision of this Amendment shall conflict with the terms of the Agreement, the terms of this Amendment shall govern and control. Seller hereby certifies to Buyer that Buyer is not in default of the Agreement as of the Effective Date, and Seller hereby agrees that Seller is estopped from claiming any breach of the Agreement due to circumstances that occurred prior to the Effective Date or facts that were known to Seller prior to the Effective Date. Buyer hereby certifies to Seller that Seller is not in default of the Agreement as of the Effective Date, and Buyer hereby agrees that Buyer is estopped from claiming any breach of the Agreement due to circumstances that occurred prior to the Effective Date or facts that were known to Buyer prior to the Effective Date.

7. Counterparts; Signatures. This Amendment may be executed in any number of counterparts. Signatures to this Amendment transmitted by email or other electronic means shall be treated as originals in all respects for purposes of this Amendment.    

8. Successors and Assigns. This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

9. Time of the Essence. Time is of the essence with respect to this Amendment and the Agreement.

[The remainder of this page is intentionally left blank – signature page follows]

 

2


IN WITNESS WHEREOF, this Amendment is executed as of the Effective Date.

SELLER:

KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation

 

By:  

                     

Name:  

 

Title:  

 

BUYER:

CAI INVESTMENTS SUB SERIES 100, LLC, a Nevada limited liability company

 

By:  

/s/ Christopher Beavor

Name:   Christopher Beavor
Title:   Manager


IN WITNESS WHEREOF, this Amendment is executed as of the Effective Date.

SELLER:

KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation

 

By:  

/s/ Donald T Gardner III

Name:   Donald T Gardner III
Title:   CFO

BUYER:

CAI INVESTMENTS SUB SERIES 100, LLC, a Nevada limited liability company

 

By:  

                     

Name:  

 

Title:  

 

EX-101.SCH 3 kequ-20220324.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 kequ-20220324_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 kequ-20220324_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
Mar. 24, 2022
Cover [Abstract]  
Entity Registrant Name KEWAUNEE SCIENTIFIC CORP /DE/
Amendment Flag false
Entity Central Index Key 0000055529
Document Type 8-K
Document Period End Date Mar. 24, 2022
Entity Incorporation State Country Code DE
Entity File Number 0-5286
Entity Tax Identification Number 38-0715562
Entity Address, Address Line One 2700 West Front Street
Entity Address, City or Town Statesville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 28677
City Area Code 704
Local Phone Number 873-7202
Security 12b Title Common Stock, $2.50 par value
Trading Symbol KEQU
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
XML 7 d340464d8k_htm.xml IDEA: XBRL DOCUMENT 0000055529 2022-03-24 2022-03-24 KEWAUNEE SCIENTIFIC CORP /DE/ false 0000055529 8-K 2022-03-24 DE 0-5286 38-0715562 2700 West Front Street Statesville NC 28677 704 873-7202 Common Stock, $2.50 par value KEQU NASDAQ false false false false false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d340464d8k.htm d340464dex105.htm kequ-20220324.xsd kequ-20220324_lab.xml kequ-20220324_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d340464d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d340464d8k.htm" ] }, "labelLink": { "local": [ "kequ-20220324_lab.xml" ] }, "presentationLink": { "local": [ "kequ-20220324_pre.xml" ] }, "schema": { "local": [ "kequ-20220324.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "kequ", "nsuri": "http://www.kewaunee.com/20220324", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d340464d8k.htm", "contextRef": "duration_2022-03-24_to_2022-03-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d340464d8k.htm", "contextRef": "duration_2022-03-24_to_2022-03-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kewaunee.com//20220324/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001193125-22-089748-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-089748-xbrl.zip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end